Mutual of America Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Mutual of America Capital Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,295	Closed	-$223K	–	1440
2024 Q4	$223K	Sell	5,295 -485	-8%	-$20.4K	﹤0.01%	1355
2024 Q3	$321K	Buy	+5,780	New	+$321K	﹤0.01%	1271
2022 Q2	–	Sell	-32,089	Closed	-$2.33M	–	1636
2022 Q1	$2.33M	Sell	32,089 -1,272	-4%	-$92.4K	0.02%	897
2021 Q4	$2.81M	Sell	33,361 -285	-0.8%	-$24K	0.03%	858
2021 Q3	$3.04M	Buy	33,646 +2,335	+7%	+$211K	0.03%	777
2021 Q2	$2.99M	Sell	31,311 -9,432	-23%	-$899K	0.03%	803
2021 Q1	$4.64M	Sell	40,743 -2,254	-5%	-$257K	0.05%	547
2020 Q4	$5.95M	Sell	42,997 -907	-2%	-$126K	0.07%	373
2020 Q3	$3.61M	Buy	43,904 +11,036	+34%	+$907K	0.05%	521
2020 Q2	$2.57M	Sell	32,868 -3,120	-9%	-$244K	0.04%	709
2020 Q1	$1.6M	Sell	35,988 -1,544	-4%	-$68.6K	0.03%	809
2019 Q4	$1.6M	Sell	37,532 -252	-0.7%	-$10.8K	0.02%	999
2019 Q3	$1.62M	Sell	37,784 -205	-0.5%	-$8.77K	0.02%	947
2019 Q2	$2.41M	Buy	37,989 +25	+0.1%	+$1.59K	0.03%	795
2019 Q1	$2.63M	Buy	37,964 +671	+2%	+$46.5K	0.04%	739
2018 Q4	$1.62M	Buy	37,293 +150	+0.4%	+$6.52K	0.03%	892
2018 Q3	$2.84M	Sell	37,143 -517	-1%	-$39.5K	0.04%	729
2018 Q2	$2.9M	Sell	37,660 -250	-0.7%	-$19.2K	0.04%	713
2018 Q1	$1.93M	Buy	37,910 +550	+1%	+$28K	0.03%	859
2017 Q4	$1.73M	Sell	37,360 -147	-0.4%	-$6.82K	0.03%	926
2017 Q3	$2M	Hold	37,507	–	–	0.03%	838
2017 Q2	$2.33M	Sell	37,507 -813	-2%	-$50.5K	0.04%	757
2017 Q1	$2.6M	Buy	38,320 +4,837	+14%	+$328K	0.05%	683
2016 Q4	$2.35M	Sell	33,483 -164	-0.5%	-$11.5K	0.04%	697
2016 Q3	$2.39M	Hold	33,647	–	–	0.05%	655
2016 Q2	$1.65M	Hold	33,647	–	–	0.04%	795
2016 Q1	$2.13M	Buy	33,647 +150	+0.4%	+$9.5K	0.05%	636
2015 Q4	$3.76M	Buy	33,497 +497	+2%	+$55.8K	0.08%	328
2015 Q3	$3.18M	Buy	33,000 +23,000	+230%	+$2.21M	0.08%	393
2015 Q2	$1.02M	Buy	+10,000	New	+$1.02M	0.02%	1003